A number of firms have modified their ratings and price targets on shares of Phreesia (NYSE: PHR) recently:
- 9/5/2026 – Phreesia was downgraded by Wall Street Zen from “buy” to “hold”.
- 9/4/2026 – Phreesia was downgraded by Weiss Ratings from “sell (d+)” to “sell (d)”.
- 9/4/2026 – Phreesia had its price target lowered by DA Davidson from $14.00 to $13.00. They now have a “buy” rating on the stock.
- 9/4/2026 – Phreesia had its price target raised by Robert W. Baird from $10.00 to $11.00. They now have a “neutral” rating on the stock.
- 9/4/2026 – Phreesia had its “market perform” rating reaffirmed by Citigroup Inc..
- 9/3/2026 – Phreesia had its price target raised by Wells Fargo & Company from $9.00 to $10.00. They now have an “equal weight” rating on the stock.
- 9/3/2026 – Phreesia had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $19.00 price target on the stock.
- 9/3/2026 – Phreesia had its “buy” rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $16.00 price target on the stock.
- 8/31/2026 – Phreesia had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $14.00 price target on the stock.
- 7/20/2026 – Phreesia was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.
Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.
Read More
- Five stocks we like better than Phreesia
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for Phreesia Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia Inc and related companies with MarketBeat.com's FREE daily email newsletter.
